Board/Management Information • Sep 6, 2022
Board/Management Information
Open in ViewerOpens in native device viewer
Changes to Biohit Oyj's management
Publishing on September 6, 2022 at 14:00 am local time (EEST)
MSc (Econ and Bus Admin) Jussi Sorvo (b. 1990) has been appointed Chief
Financial Officer and as a member of the Management Team of Biohit Oyj starting
September 7th, 2022. He will also be responsible for HR and ICT functions. Sorvo
will report to CEO Jussi Hahtela. Sorvo has worked at Biohit as a business
controller since June 2021. Previously he has worked at PwC as an auditor and in
data-analytics utilization and other reporting development projects.
Additional information:
[email protected]
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission
is “Innovating for Health” - we produce innovative products and services to
promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV)
is quoted on Nasdaq Helsinki in the Small cap/Healthcare
group.www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=ciyb_i
Z945H2z3sK3a9i7Zs03Nkj9jr5Brw7kC1tsoUye5PVgko06PC57Z9BVVT2pXUgp6sn
-tswLd2MUgQOQc8UNXD2BkNm3L02XzRJ7XfJCPaPUqGS1mpI0NZinK5T)
Attachments:
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.